Resultado de búsqueda
7 de sept. de 2022 · 7 September 2022, Cambridge, UK: STORM Therapeutics Ltd. (STORM), the biotechnology company discovering and developing novel small molecule therapies targeting RNA modification enzymes for oncology and other diseases, today announced the appointment of Dr. Gerald (Jerry) McMahon as President and Chief Executive Officer and Board ...
7 de sept. de 2022 · Industry veteran to lead STORM as it transitions into a clinical-stage company with a pipeline of products targeting RNA modifying enzymes. Dr. McMahon Joins as Board Director. CAMBRIDGE, England...
Jerry McMahon, PhD Chief Executive Officer & President Jerry has over 30 years of biotechnology leadership, scientific innovation, creative deal-making, and financing experience.
Chairman. Jerry McMahon, PhD. Chief Executive Officer & President. Christopher O’Donnell, PhD. Pfizer Venture Investments. Hakan Goker, PhD. M Ventures. Sakae Asanuma. Taiho Ventures, LLC. Professor Paul Workman, FRS, FMedSci. Chair of the Scientific Advisory Board. Professor Tony Kouzarides, PhD, FMedSci, FRS. Director & Founder.
View Jerry McMahon’s profile on LinkedIn, a professional community of 1 billion members. Dr. McMahon brings more than 30 years of exceptional biotechnology leadership, scientific…
- 500+
- STORM Therapeutics
- Yorktown High School
- San Francisco, California, United States
7 de sept. de 2022 · McMahon has held scientific, pharmaceutical and venture capital positions and has been the CEO or President of multiple biotechnology companies leading novel therapeutic programs from discovery and development to drug approvals for internal and in-licensed products.
Dr Jerry McMahon has been appointed CEO for STORM Therapeutics as it transitions into a clinical-stage company with a pipeline of products targeting RNA modifying enzymes. STORM Therapeutics is a biotechnology company specialising in discovering and developing novel small molecule therapies targeting RNA modification enzymes for oncology and ...
